New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Curaleaf Holdings, Inc.
CURA.CN
Shape
US Flag

CNQ

Unprofitable

Unprofitable

4B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

4B

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

5.22CAD
Shape0.44 ( 9.21%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

33%

Quote Panel

Shape
Updated October 14, 2024
1W % 1M % 3M % 1Y 11.13 %

Key Metrics

Shape
  • Market Cap

    4.07B


  • Shares Outstanding

    780.54M


  • Share in Float

    535.35M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    5.22


  • Average Volume

    696818


  • Beta

    1.715


  • Range

    2.965-7.84


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.curaleaf.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.18x

P/S Ratio

2.52x

P/B Ratio

0.8

Debt/Equity

-35.6%

Net Margin

$-0.9

EPS

How CURA.CN compares to sector?

P/E Ratio

Relative Strength

Shape

CURA.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape495%

2024-Revenue

$0.17

Shape-31%

2024-EPS

$74M

Shape13%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.21

arrow
arrow

N/A

-0.08
vs -0.03

Q4.21

arrow
arrow

N/A

-0.04
vs -0.05

Q1.22

arrow
arrow

N/A

NA
vs NA

Q2.22

arrow
arrow

N/A

-0.04
vs -0.01

Q3.22

arrow
arrow

N/A

-0.07
vs -0.08

Q4.22

arrow
arrow

N/A

NA
vs -0.04

Q1.23

arrow
arrow

N/A

-0.36
vs NA

Q2.23

arrow
arrow

N/A

-0.10
vs -0.04

Q3.23

arrow
arrow

N/A

-0.13
vs -0.07

Q4.23

arrow
arrow

N/A

-0.07
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.21

arrow
arrow

+74%

317.1M  vs 182.4M

Q4.21

arrow
arrow

+39%

320M  vs 230.3M

Q1.22

arrow
arrow

+20%

313.1M  vs 260.3M

Q2.22

arrow
arrow

+8%

337.6M  vs 312.2M

Q3.22

arrow
arrow

+7%

339.7M  vs 317.1M

Q4.22

arrow
arrow

+8%

346M  vs 320M

Q1.23

arrow
arrow

+7%

336.5M  vs 313.1M

Q2.23

arrow
arrow

+0%

338.6M  vs 337.6M

Q3.23

arrow
arrow

-2%

333.2M  vs 339.7M

Q4.23

arrow
arrow

+37%

473.6M  vs 346M

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-2%

-0.02
vs -0.03

Q1.22

arrow
arrow

-1%

-0.01
vs -0.02

Q2.22

arrow
arrow

-2%

-0.02
vs -0.01

Q3.22

arrow
arrow

-3%

-0.03
vs -0.02

Q4.22

arrow
arrow

-21%

-0.21
vs -0.03

Q1.23

arrow
arrow

-4%

-0.04
vs -0.21

Q2.23

arrow
arrow

-6%

-0.06
vs -0.04

Q3.23

arrow
arrow

-8%

-0.08
vs -0.06

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News